C12N 2750/14322
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2750/14322 (New viral proteins or individual genes, new structural or functional aspects of) appears on 114 US grants and 74 published applications in this corpus.
Search patents in C12N- Granted patents
- 114
- Published applications
- 74
- Assignees
- 65
- Inventors
- 209
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 1 | 0 |
| 1998 | 13 | 0 |
| 1999 | 8 | 0 |
| 2000 | 4 | 0 |
| 2001 | 10 | 1 |
| 2002 | 4 | 1 |
| 2003 | 5 | 7 |
| 2004 | 2 | 3 |
| 2005 | 2 | 1 |
| 2006 | 1 | 2 |
| 2007 | 2 | 1 |
| 2008 | 0 | 4 |
| 2009 | 1 | 2 |
| 2010 | 2 | 2 |
| 2011 | 1 | 3 |
| 2012 | 1 | 3 |
| 2013 | 3 | 6 |
| 2014 | 2 | 3 |
| 2015 | 4 | 3 |
| 2016 | 3 | 3 |
| 2017 | 5 | 2 |
| 2018 | 1 | 4 |
| 2019 | 5 | 3 |
| 2020 | 4 | 2 |
| 2021 | 1 | 3 |
| 2022 | 1 | 4 |
| 2023 | 3 | 2 |
| 2024 | 5 | 5 |
| 2025 | 2 | 1 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods12 Aug 2025US 12,383,615 B2Carbon Biosciences, Inc.
- Antibodies against disease causing agents of canines and felines and uses thereof14 Jan 2025US 12,195,500 B2Novobind Livestock Therapeutics Inc.
- cis and trans requirements for terminal resolution of human bocavirus 124 Dec 2024US 12,173,305 B2University of Iowa Research Foundation
- Bocaparvovirus small noncoding RNA and uses thereof4 Jun 2024US 11,999,965 B2University of Iowa Research Foundation
- Parvovirus structural protein for the treatment of autoimmune diseases14 May 2024US 11,981,706 B22A Pharma AB
- An aav9 capsid variant for targeted gene transfer6 Aug 2026US 2026/0224742 A1Universitaetsklinikum Hamburg-Eppendorf
- Cis and trans requirements for terminal resolution of human bocavirus 130 Apr 2026US 2026/0117253 A1University of Iowa Resarch Foundation
- A chimeric helper nucleic acid molecule comprising helper elements from three distinct helper viruses29 Jan 2026US 2026/0028643 A1Polyplus Transfection
- Adeno-associated virus compositions having increased heart enrichment12 Jun 2025US 2025/0188128 A1Capsida, Inc.
- Bocaparvovirus small noncoding rna and uses thereof21 Nov 2024US 2024/0384294 A1University of Iowa Research Foundation
Most cited
By later US patents
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Porcine circovirus and paravovirus vaccine105US 6,217,883 B1Merial Limited · 2001
- Genetically engineered vaccine strain89US 5,364,773 AVirogenetics Corporation · 1994
- Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen89US 6,265,189 B1Virogenetics Corporation · 2001